全球基因檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034）

基因檢測市場預計將從 2025 年的 48.1 億美元成長到 2034 年的 211 億美元，2026 年至 2034 年的複合年成長率為 17.86%。

受精準醫療和標靶治療快速發展的推動，全球基因檢測市場正經歷加速成長。基因檢測能夠同時分析與特定疾病相關的多個基因，尤其適用於腫瘤學、心臟病學和罕見遺傳疾病領域。全球癌症發生率的不斷攀升顯著推動了對全面腫瘤基因分析的需求。醫療機構正積極採用基因檢測來提高診斷準確性和治療方案的個人化。次世代定序（NGS）平台的技術進步正在提升偵測速度、擴充性和成本效益。

人們對遺傳疾病和預防性基因篩檢的認知不斷提高，進一步推動了市場成長。醫院和專業診斷實驗室正在擴展其分子檢測能力，以滿足日益成長的患者需求。製藥公司正在擴大基因組檢測在臨床試驗中的應用，以識別適合標靶治療的患者群體。生物技術公司與研究機構之間日益密切的合作正在加速創新。此外，已開發國家支持性的報銷政策也促進了基因檢測服務的廣泛應用。

此外，生物資訊學和數據分析技術的進步，提高了對複雜基因組數據的解讀能力，也對市場產生了正面影響。基於雲端的基因組資料庫實現了安全的數據共用和大規模研究計劃。定序技術成本的降低使得基因panel檢測在新興市場更加普及。人工智慧在基因組分析中日益廣泛的應用有望提升預測能力。伴隨診斷的監管核准也進一步刺激了市場需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球基因檢測市場：依產品與服務分類

• 市場分析、洞察與預測
• 檢測套組
• 檢查服務

第5章：全球基因檢測市場：依方法論分類

• 市場分析、洞察與預測
• 基於放大器的方法
• 基於雜合反應的方法

第6章 全球基因檢測市場：依設計分類

• 市場分析、洞察與預測
• 預先設計的基因面板
• 客製化基因面板

第7章 全球基因檢測市場：依最終用途分類

• 市場分析、洞察與預測
• 學術研究機構
• 醫院/診斷檢查室
• 製藥和生物技術公司

第8章 全球基因檢測市場：依應用分類

• 市場分析、洞察與預測
• 癌症風險評估
• 先天性疾病的診斷
• 藥物基因學
• 其他用途

第9章 全球基因檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • Illumina Inc
  • Qiagen Inc
  • Eurofins Genomics
  • Thermo Fisher Scientific
  • Foundation Medicine Inc
  • Guardant Health Inc
  • Myriad Genetic Laboratories Inc
  • Cepheid
  • Bio-Rad Laboratories Inc
  • Personalis

The Gene Panel Market size is expected to reach USD 21.10 Billion in 2034 from USD 4.81 Billion (2025) growing at a CAGR of 17.86% during 2026-2034.

The Global Gene Panel Market is experiencing accelerated growth driven by the rapid expansion of precision medicine and targeted therapies. Gene panels allow simultaneous analysis of multiple genes associated with specific diseases, particularly in oncology, cardiology, and rare genetic disorders. Increasing cancer prevalence worldwide has significantly boosted demand for comprehensive tumor profiling. Healthcare providers are adopting gene panels to improve diagnostic accuracy and treatment customization. Technological advancements in next-generation sequencing (NGS) platforms are enhancing speed, scalability, and cost-efficiency.

Rising awareness about inherited disorders and preventive genetic screening is further strengthening market growth. Hospitals and specialized diagnostic laboratories are expanding molecular testing capabilities to meet growing patient demand. Pharmaceutical companies are increasingly using gene panels in clinical trials to identify suitable patient populations for targeted drugs. Expanding collaborations between biotech firms and research institutes are accelerating innovation. Additionally, supportive reimbursement policies in developed economies are encouraging broader adoption of genetic testing services.

The market is also benefiting from advancements in bioinformatics and data analytics, which improve interpretation of complex genomic data. Cloud-based genomic databases enable secure data sharing and large-scale research initiatives. The decreasing cost of sequencing technologies is making gene panel testing more accessible in emerging markets. Growing integration of artificial intelligence in genomic analysis is expected to enhance predictive capabilities. Regulatory approvals for companion diagnostics are further driving demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Test Kits
• Testing Services

By Technique

• Amplicon Based Approach
• Hybridization Based Approach

By Design

• Predesigned Gene Panel
• Customized Gene Panel

By End Use

• Academic & Research Institutes
• Hospital & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies

By Application

• Cancer Risk Assessment
• Diagnosis of Congenital Diseases
• Pharmacogenetics
• Other Applications

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, Qiagen Inc, Eurofins Genomics, Thermo Fisher Scientific, Foundation Medicine Inc, Guardant Health Inc, Myriad Genetic Laboratories Inc, Cepheid, BioRad Laboratories Inc, Personalis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE PANEL MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE PANEL MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique
• 5.2. Amplicon Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hybridization Based Approach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE PANEL MARKET: BY DESIGN 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Design
• 6.2. Predesigned Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Customized Gene Panel Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE PANEL MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospital & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENE PANEL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Application
• 8.2. Cancer Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Diagnosis of Congenital Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmacogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL GENE PANEL MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Services
  • 9.2.2 By Technique
  • 9.2.3 By Design
  • 9.2.4 By End Use
  • 9.2.5 By Application
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Services
  • 9.3.2 By Technique
  • 9.3.3 By Design
  • 9.3.4 By End Use
  • 9.3.5 By Application
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Services
  • 9.4.2 By Technique
  • 9.4.3 By Design
  • 9.4.4 By End Use
  • 9.4.5 By Application
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Services
  • 9.5.2 By Technique
  • 9.5.3 By Design
  • 9.5.4 By End Use
  • 9.5.5 By Application
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Services
  • 9.6.2 By Technique
  • 9.6.3 By Design
  • 9.6.4 By End Use
  • 9.6.5 By Application
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL GENE PANEL INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies
  • 11.2.2 Illumina Inc
  • 11.2.3 Qiagen Inc
  • 11.2.4 Eurofins Genomics
  • 11.2.5 Thermo Fisher Scientific
  • 11.2.6 Foundation Medicine Inc
  • 11.2.7 Guardant Health Inc
  • 11.2.8 Myriad Genetic Laboratories Inc
  • 11.2.9 Cepheid
  • 11.2.10 Bio-Rad Laboratories Inc
  • 11.2.11 Personalis